LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 208 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $980,000 | +357.9% | 6,348 | +311.7% | 0.00% | +100.0% |
| Q3 2021 | $214,000 | +5.9% | 1,542 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $202,000 | -15.5% | 1,542 | -1.8% | 0.00% | 0.0% |
| Q1 2021 | $239,000 | +2.6% | 1,571 | -35.8% | 0.00% | 0.0% |
| Q3 2020 | $233,000 | -11.7% | 2,448 | +3.5% | 0.00% | 0.0% |
| Q2 2020 | $264,000 | +21.7% | 2,365 | +13.2% | 0.00% | 0.0% |
| Q4 2019 | $217,000 | -16.2% | 2,090 | -19.8% | 0.00% | 0.0% |
| Q3 2019 | $259,000 | -54.7% | 2,605 | -48.0% | 0.00% | -66.7% |
| Q2 2019 | $572,000 | +18.4% | 5,011 | +30.3% | 0.00% | +50.0% |
| Q1 2019 | $483,000 | +10.3% | 3,847 | +141.0% | 0.00% | 0.0% |
| Q3 2018 | $438,000 | +101.8% | 1,596 | +52.3% | 0.00% | +100.0% |
| Q2 2018 | $217,000 | +9.0% | 1,048 | -13.3% | 0.00% | 0.0% |
| Q1 2018 | $199,000 | -2.9% | 1,209 | -19.2% | 0.00% | 0.0% |
| Q4 2017 | $205,000 | – | 1,497 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |